Nicholas Magnus (CPR&D, Eli Lilly and Company)
"Glucokinase Activator - Type 2 Diabetes: Development of an Enantioselective Hydrogenation Based Process"
"Glucokinase Activator - Type 2 Diabetes: Development of an Enantioselective Hydrogenation Based Process"